Ithaca, NY, United States of America

Matthew DeLisa

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Austin, TX (US) (2008)
  • Ithaca, NY (US) (2014 - 2023)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: A Closer Look at Inventor Matthew DeLisa in Ithaca, NY

Introduction: Matthew DeLisa is a prominent inventor based in Ithaca, New York, holding an impressive total of 23 patents. His work primarily focuses on the innovative field of bioconjugate vaccines, employing cutting-edge methods for glycoprotein synthesis.

Latest Patents: Among his latest patents, DeLisa has developed compositions and methods for rapid in vitro synthesis of bioconjugate vaccines. This invention details methods, systems, components, and compositions for cell-free synthesis of glycosylated carrier proteins. These proteins can be vital in vaccines, including anti-bacterial vaccines, facilitating an immune response in immunized hosts. DeLisa's work on the rapid in vitro synthesis of glycoproteins via recombinant production also highlights the use of prokaryotic cell lysates enriched in essential components for glycoprotein synthesis.

Career Highlights: DeLisa's career is marked by significant contributions to vaccine development, with his innovative methodologies leading to advancements in the synthesis of glycoproteins. His extensive research has benefitted from his affiliations with reputable institutions such as Cornell University and the Cornell Research Foundation Inc.

Collaborations: Throughout his career, DeLisa has collaborated with other notable researchers, including Michael Christopher Jewett and Jessica Carol Stark. These partnerships have enhanced his research initiatives, fostering advancements in the field of bioconjugate vaccine technology.

Conclusion: Matthew DeLisa’s contributions to the field of biotechnological innovations, particularly in vaccine development, underscore his role as a leading inventor in his domain. With a robust portfolio of patents, he continues to push the boundaries of science and technology, offering promising solutions for public health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…